Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

Zi-Yang ShiYing FangPeng-Peng XuHong-Mei YiJian-Feng LiYan DongYue ZhuMeng-Ke LiuDi FuShuo WangQing ShiRong ShenHui-Juan ZhongChao-Fu WangShu ChengLi WangFeng LiuWei Li Zhao

Published in: Clinical and translational medicine (2024)

Keyphrases

histone deacetylase
diffuse large b cell lymphoma
single cell
transcription factor
single molecule